EPS for FibroGen, Inc. (FGEN) Expected At $-0.27; Jacobs Levy Equity Management Has Upped By $1.91 Million Its Astronics (ATRO) Holding – The InvestReporter

EPS for FibroGen, Inc. (FGEN) Expected At $-0.27; Jacobs Levy Equity Management Has Upped By $1.91 Million Its Astronics (ATRO) Holding  The InvestReporter

Analysts expect FibroGen, Inc. (NASDAQ:FGEN) to report $-0.27 EPS on August, 6.They anticipate $0.01 EPS change or 3.57% from last quarter’s $-0.28 EPS.